$CYRX
Cryoport, Inc.

2024 Q3 Form 10-Q Financial Statement

#000155837024011562 Filed on August 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $56.66M $57.60M
YoY Change 0.9% 1.01%
Cost Of Revenue $31.28M $32.41M
YoY Change -1.92% 0.37%
Gross Profit $25.39M $25.19M
YoY Change 4.61% 1.85%
Gross Profit Margin 44.8% 43.73%
Selling, General & Admin $37.65M $35.96M
YoY Change 4.53% -7.32%
% of Gross Profit 148.33% 142.77%
Research & Development $4.157M $4.646M
YoY Change -19.31% 8.98%
% of Gross Profit 16.38% 18.44%
Depreciation & Amortization $7.836M $7.558M
YoY Change 13.4% 12.42%
% of Gross Profit 30.87% 30.0%
Operating Expenses $41.81M $104.4M
YoY Change 1.54% 142.47%
Operating Profit -$16.43M -$79.23M
YoY Change -2.86% 332.18%
Interest Expense $2.170M $1.564M
YoY Change 59.91% 17.51%
% of Operating Profit
Other Income/Expense, Net $17.88M $1.622M
YoY Change 334.93% 165.03%
Pretax Income $1.454M -$77.61M
YoY Change -111.36% 337.96%
Income Tax $649.0K $383.0K
% Of Pretax Income 44.64%
Net Earnings $805.0K -$77.99M
YoY Change -106.07% 324.89%
Net Earnings / Revenue 1.42% -135.4%
Basic Earnings Per Share -$0.02 -$1.62
Diluted Earnings Per Share -$0.02 -$1.62
COMMON SHARES
Basic Shares Outstanding 49.41M 49.26M
Diluted Shares Outstanding 49.42M 49.35M

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $272.7M $427.1M
YoY Change -41.48% -15.36%
Cash & Equivalents $44.67M $46.46M
Short-Term Investments $228.0M $380.7M
Other Short-Term Assets $10.66M $11.08M
YoY Change -7.32% 28.54%
Inventory $23.55M $23.61M
Prepaid Expenses
Receivables $43.46M $40.16M
Other Receivables $0.00 $0.00
Total Short-Term Assets $350.3M $502.0M
YoY Change -36.2% -14.22%
LONG-TERM ASSETS
Property, Plant & Equipment $88.28M $86.65M
YoY Change 18.47% 25.57%
Goodwill $54.06M $52.38M
YoY Change -63.71% -64.92%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.162M $3.246M
YoY Change 26.48% 51.4%
Total Long-Term Assets $351.4M $350.4M
YoY Change -22.17% -21.35%
TOTAL ASSETS
Total Short-Term Assets $350.3M $502.0M
Total Long-Term Assets $351.4M $350.4M
Total Assets $701.8M $852.3M
YoY Change -29.87% -17.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $25.19M $24.81M
YoY Change -9.7% -5.05%
Accrued Expenses $17.11M $15.99M
YoY Change 12.56% 23.46%
Deferred Revenue $1.091M $1.317M
YoY Change -30.95% 42.07%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $14.89M $14.72M
YoY Change 14794.0% 24029.51%
Total Short-Term Liabilities $61.44M $59.89M
YoY Change 36.82% 48.77%
LONG-TERM LIABILITIES
Long-Term Debt $186.2M $358.1M
YoY Change -50.87% -12.45%
Other Long-Term Liabilities $569.0K $427.0K
YoY Change 17.56% 18.28%
Total Long-Term Liabilities $569.0K $427.0K
YoY Change 17.56% 18.28%
TOTAL LIABILITIES
Total Short-Term Liabilities $61.44M $59.89M
Total Long-Term Liabilities $569.0K $427.0K
Total Liabilities $283.2M $452.2M
YoY Change -38.85% -7.02%
SHAREHOLDERS EQUITY
Retained Earnings -$738.5M -$739.3M
YoY Change 27.32% 30.44%
Common Stock $49.00K $49.00K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $418.6M $400.1M
YoY Change
Total Liabilities & Shareholders Equity $701.8M $852.3M
YoY Change -29.87% -17.3%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income $805.0K -$77.99M
YoY Change -106.07% 324.89%
Depreciation, Depletion And Amortization $7.836M $7.558M
YoY Change 13.4% 12.42%
Cash From Operating Activities $447.0K -$8.025M
YoY Change -122.81% 97.95%
INVESTING ACTIVITIES
Capital Expenditures $5.089M $5.770M
YoY Change -55.71% -47.35%
Acquisitions
YoY Change
Other Investing Activities $158.7M $19.09M
YoY Change 428.86% -57.23%
Cash From Investing Activities $153.6M $13.32M
YoY Change 729.66% -60.45%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -155.3M -8.764M
YoY Change 523.91% -863.41%
NET CHANGE
Cash From Operating Activities 447.0K -8.025M
Cash From Investing Activities 153.6M 13.32M
Cash From Financing Activities -155.3M -8.764M
Net Change In Cash -1.274M -3.468M
YoY Change -84.72% -111.27%
FREE CASH FLOW
Cash From Operating Activities $447.0K -$8.025M
Capital Expenditures $5.089M $5.770M
Free Cash Flow -$4.642M -$13.79M
YoY Change -65.49% -8.11%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001124524
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-34632
dei Entity Registrant Name
EntityRegistrantName
CRYOPORT, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
88-0313393
dei Entity Address Address Line1
EntityAddressAddressLine1
112 Westwood Place, Suite 350
dei Entity Address City Or Town
EntityAddressCityOrTown
Brentwood
dei Entity Address State Or Province
EntityAddressStateOrProvince
TN
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
37027
dei City Area Code
CityAreaCode
949
dei Local Phone Number
LocalPhoneNumber
470-2300
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
dei Trading Symbol
TradingSymbol
CYRX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
49412294
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
46458000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
46346000
CY2024Q2 us-gaap Short Term Investments
ShortTermInvestments
380684000
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
410409000
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
40160000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
42074000
CY2024Q2 us-gaap Inventory Net
InventoryNet
23609000
CY2023Q4 us-gaap Inventory Net
InventoryNet
26206000
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
11075000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10077000
CY2024Q2 us-gaap Assets Current
AssetsCurrent
501986000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
535112000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
86653000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
84858000
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
29684000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
32653000
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
178388000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
194382000
CY2024Q2 us-gaap Goodwill
Goodwill
52384000
CY2023Q4 us-gaap Goodwill
Goodwill
108403000
CY2024Q2 us-gaap Deposits Assets
DepositsAssets
1668000
CY2023Q4 us-gaap Deposits Assets
DepositsAssets
1680000
CY2024Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1578000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
656000
CY2024Q2 us-gaap Assets
Assets
852341000
CY2023Q4 us-gaap Assets
Assets
957744000
CY2024Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
24805000
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
26995000
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
10690000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
11409000
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1317000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1308000
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5299000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5371000
CY2024Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
365000
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
286000
CY2024Q2 cyrx Convertible Subordinated Debt Current Discount
ConvertibleSubordinatedDebtCurrentDiscount
100000
CY2024Q2 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
14244000
CY2024Q2 us-gaap Notes Payable Current
NotesPayableCurrent
110000
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
149000
CY2024Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
3055000
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
92000
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
59885000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
45610000
CY2024Q2 cyrx Convertible Subordinated Debt Noncurrent Discount
ConvertibleSubordinatedDebtNoncurrentDiscount
5500000
CY2023Q4 cyrx Convertible Subordinated Debt Noncurrent Discount
ConvertibleSubordinatedDebtNoncurrentDiscount
7000000.0
CY2024Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
355665000
CY2023Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
378553000
CY2024Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
1258000
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
1335000
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
26523000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
29355000
CY2024Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
1137000
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
954000
CY2024Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2651000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2816000
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
427000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
601000
CY2024Q2 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
4700000
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
9497000
CY2024Q2 us-gaap Liabilities
Liabilities
452246000
CY2023Q4 us-gaap Liabilities
Liabilities
468721000
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2500000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2500000
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49412294
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
49412294
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
48971026
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
48971026
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
49000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
49000
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1138263000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1131183000
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-739303000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-642419000
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-29189000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-26065000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
400095000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
489023000
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
852341000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
957744000
CY2024Q2 us-gaap Revenues
Revenues
57597000
CY2023Q2 us-gaap Revenues
Revenues
57021000
us-gaap Revenues
Revenues
112189000
us-gaap Revenues
Revenues
119838000
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
32407000
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
32288000
us-gaap Cost Of Revenue
CostOfRevenue
65224000
us-gaap Cost Of Revenue
CostOfRevenue
68033000
CY2024Q2 us-gaap Gross Profit
GrossProfit
25190000
CY2023Q2 us-gaap Gross Profit
GrossProfit
24733000
us-gaap Gross Profit
GrossProfit
46965000
us-gaap Gross Profit
GrossProfit
51805000
CY2024Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
35963000
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
38802000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
74267000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
72043000
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4646000
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4263000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9398000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8139000
CY2024Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
63809000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
63809000
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
104418000
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
43065000
us-gaap Operating Expenses
OperatingExpenses
147474000
us-gaap Operating Expenses
OperatingExpenses
80182000
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-79228000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-18332000
us-gaap Operating Income Loss
OperatingIncomeLoss
-100509000
us-gaap Operating Income Loss
OperatingIncomeLoss
-28377000
CY2024Q2 us-gaap Investment Income Net
InvestmentIncomeNet
2809000
CY2023Q2 us-gaap Investment Income Net
InvestmentIncomeNet
2647000
us-gaap Investment Income Net
InvestmentIncomeNet
5409000
us-gaap Investment Income Net
InvestmentIncomeNet
5114000
CY2024Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1245000
CY2023Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1331000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
2583000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
2840000
CY2024Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1179000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1179000
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1121000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-704000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
218000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3301000
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1622000
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
612000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4223000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5575000
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-77606000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17720000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-96286000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22802000
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
383000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
635000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
598000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1127000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-77989000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-18355000
us-gaap Net Income Loss
NetIncomeLoss
-96884000
us-gaap Net Income Loss
NetIncomeLoss
-23929000
CY2024Q2 cyrx Paid In Kind Dividend On Series C Convertible Preferred Stock Value
PaidInKindDividendOnSeriesCConvertiblePreferredStockValue
2000000
CY2023Q2 cyrx Paid In Kind Dividend On Series C Convertible Preferred Stock Value
PaidInKindDividendOnSeriesCConvertiblePreferredStockValue
2000000
cyrx Paid In Kind Dividend On Series C Convertible Preferred Stock Value
PaidInKindDividendOnSeriesCConvertiblePreferredStockValue
4000000
cyrx Paid In Kind Dividend On Series C Convertible Preferred Stock Value
PaidInKindDividendOnSeriesCConvertiblePreferredStockValue
4000000
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-79989000
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-79989000
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-20355000
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-20355000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-100884000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-100884000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-27929000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-27929000
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.62
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.62
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.42
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.42
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.58
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.58
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49345644
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48709384
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49182830
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48536901
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-77989000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-18355000
us-gaap Net Income Loss
NetIncomeLoss
-96884000
us-gaap Net Income Loss
NetIncomeLoss
-23929000
CY2024Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
994000
CY2023Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-1223000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
1255000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
2452000
CY2024Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-695000
CY2023Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-532000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
1619000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-631000
CY2024Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-801000
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-4226000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-2760000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-3022000
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
888000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4917000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-3124000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
61000
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-77101000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23272000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-100008000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23868000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
560518000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-18355000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4917000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5800000
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1209000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
544255000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
472190000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-77989000
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
888000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4997000
CY2024Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
9000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
400095000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
555838000
us-gaap Net Income Loss
NetIncomeLoss
-23929000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
61000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10984000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1301000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
544255000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
489023000
us-gaap Net Income Loss
NetIncomeLoss
-96884000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-3124000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10453000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
627000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
400095000
us-gaap Profit Loss
ProfitLoss
-96884000
us-gaap Profit Loss
ProfitLoss
-23929000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
63809000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
15027000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
13127000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1198000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1283000
us-gaap Operating Lease Expense
OperatingLeaseExpense
2826000
us-gaap Operating Lease Expense
OperatingLeaseExpense
2281000
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-1026000
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
105000
cyrx Realized Loss On Investments In Equity Securities
RealizedLossOnInvestmentsInEquitySecurities
-1968000
cyrx Realized Loss On Investments In Equity Securities
RealizedLossOnInvestmentsInEquitySecurities
69000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1179000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10453000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10984000
us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
-238000
us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
-190000
cyrx Gain Loss On Insurance Settlement
GainLossOnInsuranceSettlement
2642000
cyrx Increase Decrease In Credit Losses
IncreaseDecreaseInCreditLosses
-18000
cyrx Increase Decrease In Credit Losses
IncreaseDecreaseInCreditLosses
-133000
us-gaap Proceeds From Insurance Settlement Operating Activities
ProceedsFromInsuranceSettlementOperatingActivities
1212000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-1741000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-68000
us-gaap Increase Decrease In Long Term Receivables Current
IncreaseDecreaseInLongTermReceivablesCurrent
-1558000
us-gaap Increase Decrease In Long Term Receivables Current
IncreaseDecreaseInLongTermReceivablesCurrent
-1104000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2432000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1247000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1381000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1251000
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
9000
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
197000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-2754000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-2102000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2294000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2874000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-630000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
248000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
23000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
488000
cyrx Net Deferred Tax Expense Income
NetDeferredTaxExpenseIncome
-1022000
cyrx Net Deferred Tax Expense Income
NetDeferredTaxExpenseIncome
-220000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11290000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1280000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7796000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
18243000
cyrx Payments For Proceeds From Insurance Proceeds For Loss From Fixed Assets
PaymentsForProceedsFromInsuranceProceedsForLossFromFixedAssets
-976000
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
2074000
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
2534000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
49922000
us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
80225000
us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
52487000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
667000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
391000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
19766000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
32295000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
627000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1300000
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
8663000
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-72000
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-11000
cyrx Repayment Of Finance Lease Liabilities
RepaymentOfFinanceLeaseLiabilities
144000
cyrx Repayment Of Finance Lease Liabilities
RepaymentOfFinanceLeaseLiabilities
70000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-8252000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1219000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-112000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1515000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
112000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
30719000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
46346000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36595000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
46458000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
67314000
us-gaap Interest Paid Net
InterestPaidNet
1611000
us-gaap Interest Paid Net
InterestPaidNet
1725000
us-gaap Income Taxes Paid
IncomeTaxesPaid
707000
us-gaap Income Taxes Paid
IncomeTaxesPaid
1103000
cyrx Operating Lease Right Of Use Assets And Lease Liabilities
OperatingLeaseRightOfUseAssetsAndLeaseLiabilities
186000
cyrx Operating Lease Right Of Use Assets And Lease Liabilities
OperatingLeaseRightOfUseAssetsAndLeaseLiabilities
5603000
cyrx Non Cash Net Unrealized Gain Loss On Available For Sale Securities
NonCashNetUnrealizedGainLossOnAvailableForSaleSecurities
1255000
cyrx Non Cash Net Unrealized Gain Loss On Available For Sale Securities
NonCashNetUnrealizedGainLossOnAvailableForSaleSecurities
2452000
cyrx Reclassification Of Realized Gain On Available For Sale Debt Securities To Earnings
ReclassificationOfRealizedGainOnAvailableForSaleDebtSecuritiesToEarnings
1619000
cyrx Reclassification Of Realized Gain On Available For Sale Debt Securities To Earnings
ReclassificationOfRealizedGainOnAvailableForSaleDebtSecuritiesToEarnings
-631000
cyrx Paid In Kind Preferred Stock Dividend Including Beneficial Conversion Feature
PaidInKindPreferredStockDividendIncludingBeneficialConversionFeature
4000000
cyrx Paid In Kind Preferred Stock Dividend Including Beneficial Conversion Feature
PaidInKindPreferredStockDividendIncludingBeneficialConversionFeature
4000000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
464000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
822000
us-gaap Nature Of Operations
NatureOfOperations
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Note 2. Nature of the Business</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Cryoport is a leading global provider of innovative products and services supporting the life sciences. Our mission is to enable the future of medicine for a new era of life sciences. With over 50 strategic locations covering the Americas, EMEA (Europe, the Middle East and Africa) and APAC (Asia Pacific), Cryoport's global platform provides mission-critical bio-logistics, bio-storage, bio-processing, and cryogenic systems to over 3,000 customers worldwide. Our platform of solutions and services, together with our global team of over 1,100 dedicated colleagues, delivers a unique combination of innovative supply chain technologies and services through our industry-leading brands, including Cryoport Systems, MVE Biological Solutions (MVE), CRYOPDP, and CRYOGENE.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">The Company is a Nevada corporation and its common stock is traded on the NASDAQ Capital Market exchange under the ticker symbol “CYRX.”</p>
cyrx Number Of Strategic Locations
NumberOfStrategicLocations
50
cyrx Number Of Customers
NumberOfCustomers
3000
CY2024Q2 dei Entity Number Of Employees
EntityNumberOfEmployees
1100
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-2800000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-3000000.0
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
us-gaap Number Of Reporting Units
NumberOfReportingUnits
1
CY2024Q2 us-gaap Revenues
Revenues
57597000
CY2023Q2 us-gaap Revenues
Revenues
57021000
us-gaap Revenues
Revenues
112189000
us-gaap Revenues
Revenues
119838000
CY2024Q2 us-gaap Revenues
Revenues
57597000
CY2023Q2 us-gaap Revenues
Revenues
57021000
us-gaap Revenues
Revenues
112189000
us-gaap Revenues
Revenues
119838000
CY2024Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1300000
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1300000
CY2024Q2 cyrx Contract With Customer Liability Revenue Recognized Excluding Opening Balance
ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance
200000
CY2023Q2 cyrx Contract With Customer Liability Revenue Recognized Excluding Opening Balance
ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance
500000
cyrx Contract With Customer Liability Revenue Recognized Excluding Opening Balance
ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance
600000
cyrx Contract With Customer Liability Revenue Recognized Excluding Opening Balance
ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance
900000
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2100000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2000000.0
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1992000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1275000
us-gaap Accounts Receivable Change In Method Credit Loss Expense Reversal
AccountsReceivableChangeInMethodCreditLossExpenseReversal
-147000
CY2023 us-gaap Accounts Receivable Change In Method Credit Loss Expense Reversal
AccountsReceivableChangeInMethodCreditLossExpenseReversal
-812000
cyrx Accounts Receivable Allowance For Credit Loss Writeoff Net Of Recoveries
AccountsReceivableAllowanceForCreditLossWriteoffNetOfRecoveries
57000
CY2023 cyrx Accounts Receivable Allowance For Credit Loss Writeoff Net Of Recoveries
AccountsReceivableAllowanceForCreditLossWriteoffNetOfRecoveries
95000
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2082000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1992000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-77989000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-18355000
us-gaap Net Income Loss
NetIncomeLoss
-96884000
us-gaap Net Income Loss
NetIncomeLoss
-23929000
CY2024Q2 cyrx Paid In Kind Dividend On Series C Convertible Preferred Stock Value
PaidInKindDividendOnSeriesCConvertiblePreferredStockValue
2000000
CY2023Q2 cyrx Paid In Kind Dividend On Series C Convertible Preferred Stock Value
PaidInKindDividendOnSeriesCConvertiblePreferredStockValue
2000000
cyrx Paid In Kind Dividend On Series C Convertible Preferred Stock Value
PaidInKindDividendOnSeriesCConvertiblePreferredStockValue
4000000
cyrx Paid In Kind Dividend On Series C Convertible Preferred Stock Value
PaidInKindDividendOnSeriesCConvertiblePreferredStockValue
4000000
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-79989000
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-20355000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-100884000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-27929000
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49345644
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49345644
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48709384
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48709384
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49182830
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49182830
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48536901
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48536901
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.62
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.62
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.42
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.42
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.58
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.58
CY2024Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12703514
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13906797
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12368614
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13994839
CY2024Q2 us-gaap Cash
Cash
40988000
CY2023Q4 us-gaap Cash
Cash
40979000
CY2024Q2 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
5470000
CY2023Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
5367000
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
46458000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
46346000
CY2024Q2 us-gaap Short Term Investments
ShortTermInvestments
380684000
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
410409000
CY2024Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
427142000
CY2023Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
456755000
CY2024Q2 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
279370000
CY2024Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1893000
CY2024Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
638000
CY2024Q2 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
280625000
CY2024Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
111715000
CY2024Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
113011000
CY2024Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
167655000
CY2024Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
167614000
CY2024Q2 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
279370000
CY2024Q2 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
280625000
CY2023Q4 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
302581000
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
6764000
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
22000
CY2023Q4 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
309323000
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
101252000
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
103802000
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
201329000
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
205521000
CY2023Q4 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
302581000
CY2023Q4 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
309323000
CY2024Q2 cyrx Available For Sale Securities Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesUnrealizedLossPositionLessThanTwelveMonthsFairValue
79268000
CY2024Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
335000
CY2024Q2 cyrx Available For Sale Securities Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesUnrealizedLossPositionTwelveMonthsOrLongerFairValue
201357000
CY2024Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
302000
CY2024Q2 cyrx Available For Sale Securities Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesUnrealizedLossPositionFairValue
280625000
CY2024Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
637000
CY2024Q2 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
-450000
CY2023Q2 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
20000.00
us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
1970000
us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
-70000.00
CY2024Q2 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
100100000
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
-1026000
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
-1405000
cyrx Equity Securities Realized Gain Loss Sold
EquitySecuritiesRealizedGainLossSold
1510000
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-1026000
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
105000
CY2024Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
14831000
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
15335000
CY2024Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1156000
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1375000
CY2024Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
7622000
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
9496000
CY2024Q2 us-gaap Inventory Net
InventoryNet
23609000
CY2023Q4 us-gaap Inventory Net
InventoryNet
26206000
CY2023Q4 us-gaap Goodwill
Goodwill
108403000
CY2022Q4 us-gaap Goodwill
Goodwill
151117000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-1456000
CY2023 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-284000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
54563000
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
49569000
CY2024Q2 us-gaap Goodwill
Goodwill
52384000
CY2023Q4 us-gaap Goodwill
Goodwill
108403000
CY2024Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
250588000
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
62955000
CY2024Q2 cyrx Finite Lived Intangible Assets Accumulated Impairment
FiniteLivedIntangibleAssetsAccumulatedImpairment
9245000
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
178388000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
247250000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
52868000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
194382000
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4300000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
8700000
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3900000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7700000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
8237000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
15041000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
14760000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
14391000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
13363000
CY2024Q2 cyrx Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
70771000
CY2024Q2 cyrx Future Amortization Of Finite Lived Intangible Assets
FutureAmortizationOfFiniteLivedIntangibleAssets
136563000
CY2024Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
5620000
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
6976000
CY2024Q2 us-gaap Convertible Debt
ConvertibleDebt
369909000
CY2023Q4 us-gaap Convertible Debt
ConvertibleDebt
378553000
CY2024Q2 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
14244000
CY2024Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
355665000
CY2023Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
378553000
CY2024Q2 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
us-gaap Operating Lease Cost
OperatingLeaseCost
3981000
us-gaap Operating Lease Cost
OperatingLeaseCost
3453000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
191000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
79000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
64000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
19000
cyrx Finance Lease Cost
FinanceLeaseCost
255000
cyrx Finance Lease Cost
FinanceLeaseCost
98000
us-gaap Lease Cost
LeaseCost
4236000
us-gaap Lease Cost
LeaseCost
3551000
us-gaap Operating Lease Payments
OperatingLeasePayments
3913000
us-gaap Operating Lease Payments
OperatingLeasePayments
3323000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
226000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
89000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
144000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
70000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
186000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
5603000
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
453000
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
538000
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y6M
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P10Y9M18D
CY2024Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P3Y10M24D
CY2023Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P4Y2M12D
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.082
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.087
CY2024Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.086
CY2023Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.084
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
3918000
CY2024Q2 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
238000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
6922000
CY2024Q2 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
473000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
5663000
CY2024Q2 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
447000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
4875000
CY2024Q2 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
336000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
3659000
CY2024Q2 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
243000
CY2024Q2 cyrx Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
22621000
CY2024Q2 cyrx Finance Lease Liability Payments Due After Year Four
FinanceLeaseLiabilityPaymentsDueAfterYearFour
29000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
47658000
CY2024Q2 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
1766000
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
15836000
CY2024Q2 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
264000
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
31822000
CY2024Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
1502000
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5299000
CY2024Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
365000
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
26523000
CY2024Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
1137000
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
31822000
CY2024Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
1502000
CY2022Q1 us-gaap Unusual Or Infrequent Item Loss Gross
UnusualOrInfrequentItemLossGross
9400000
CY2024Q1 us-gaap Unusual Or Infrequent Item Insurance Proceeds
UnusualOrInfrequentItemInsuranceProceeds
15100000
CY2023Q1 us-gaap Unusual Or Infrequent Item Insurance Proceeds
UnusualOrInfrequentItemInsuranceProceeds
2200000
us-gaap Gain On Business Interruption Insurance Recovery
GainOnBusinessInterruptionInsuranceRecovery
2600000
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2500000
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
18100000
CY2024Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
18138079
CY2024Q2 us-gaap Share Based Compensation
ShareBasedCompensation
4997000
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
5800000
us-gaap Share Based Compensation
ShareBasedCompensation
10453000
us-gaap Share Based Compensation
ShareBasedCompensation
10984000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7224820
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
15.88
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.81
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
308643
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
14.26
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
116514
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
5.39
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
72063
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
34.37
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7344886
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
15.80
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y10M24D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
6452000
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
6528307
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
14.62
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P3Y8M12D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
6452000
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
816579
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
25.24
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y9M18D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
6.91
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1100000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
5900000
CY2024Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
11000000.0
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
cyrx-20240630_cal.xml Edgar Link unprocessable
0001558370-24-011562-index-headers.html Edgar Link pending
0001558370-24-011562-index.html Edgar Link pending
0001558370-24-011562.txt Edgar Link pending
0001558370-24-011562-xbrl.zip Edgar Link pending
cyrx-20240630.xsd Edgar Link pending
cyrx-20240630x10q.htm Edgar Link pending
cyrx-20240630x10q004.jpg Edgar Link pending
cyrx-20240630xex31d1.htm Edgar Link pending
cyrx-20240630xex31d2.htm Edgar Link pending
cyrx-20240630xex32d1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
cyrx-20240630_def.xml Edgar Link unprocessable
cyrx-20240630_lab.xml Edgar Link unprocessable
cyrx-20240630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cyrx-20240630x10q_htm.xml Edgar Link completed
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending